Indole-3-acetamide → 3-[6-[tert-butylsilyloxy(diphenyl)methyl]-2-methylimidazo[1,2-a]pyrazin-3-yl]-4-(1H-indol-3-yl)pyrrole-2,5-dione

HRID 402879

Reaktionsgleichung

Reaktionsgleichung von HRID 402879
CC(C)([O-])C.[K+].[NH:7]1[C:15]2[C:10](=[CH:11][CH:12]=[CH:13][CH:14]=2)[C:9]([CH2:16][C:17]([NH2:19])=[O:18])=[CH:8]1.C([O:22][C:23](=O)[C:24]([C:26]1[N:30]2[CH:31]=[C:32]([C:35]([C:48]3[CH:53]=[CH:52][CH:51]=[CH:50][CH:49]=3)([C:42]3[CH:47]=[CH:46][CH:45]=[CH:44][CH:43]=3)[O:36][SiH2:37][C:38]([CH3:41])([CH3:40])[CH3:39])[N:33]=[CH:34][C:29]2=[N:28][C:27]=1[CH3:54])=O)C.[NH4+].[Cl-].C1CCN2C(=NCCC2)CC1>O1CCCC1.CCOC(C)=O.O>[C:38]([SiH2:37][O:36][C:35]([C:42]1[CH:43]=[CH:44][CH:45]=[CH:46][CH:47]=1)([C:48]1[CH:53]=[CH:52][CH:51]=[CH:50][CH:49]=1)[C:32]1[N:33]=[CH:34][C:29]2[N:30]([C:26]([C:24]3[C:23](=[O:22])[NH:19][C:17](=[O:18])[C:16]=3[C:9]3[C:10]4[C:15](=[CH:14][CH:13]=[CH:12][CH:11]=4)[NH:7][CH:8]=3)=[C:27]([CH3:54])[N:28]=2)[CH:31]=1)([CH3:41])([CH3:39])[CH3:40]

Komponenten

9

Edukt 5

HCID 397Indole-3-acetamideHCID 25517Ammonium ChlorideHCID 811841,8-Diazabicyclo(5.4.0)undec-7-eneHCID 23665647Potassium tert-butoxideHCID 131729752[6-(Tert-butyl-diphenyl-silanyloxymethyl)-2-methyl-imidazo[1,2-a]pyrazin-3-yl]-oxo-acetic acid ethyl ester

Produkt 1

HCID 1540901423-[6-[tert-butylsilyloxy(diphenyl)methyl]-2-methylimidazo[1,2-a]pyrazin-3-yl]-4-(1H-indol-3-yl)pyrrole-2,5-dione

Reagenzien, Katalysatoren, Lösungsmittel 3

HCID 962WaterLösungsmittelHCID 8028TetrahydrofuranLösungsmittelHCID 8857Ethyl AcetateLösungsmittel

Versuchsvorschrift

Potassium tert-butoxide (1.0 M in THF, 0.86 ml, 0.86 mmol, 3.0 equiv) is added dropwise at room temperature under an atmosphere of argon to a solution of 2-(1H-indol-3-yl)-acetamide (50 mg, 0.29 mmol, 1.0 equiv) and of [6-(tert-butyl-diphenyl-silanyloxymethyl)-2-methyl-imidazo[1,2-a]pyrazin-3-yl]-oxo-acetic acid ethyl ester (158 mg, 0.32 mmol, 1.0 equiv) in anhydrous tetrahydrofuran (1.0 ml, dried over molecular sieves). The reaction mixture is stirred for 15 minutes at room temperature. It is then diluted with EtOAc and poured into a saturated aqueous NH4Cl solution. After three extractions with EtOAc, the combined organic layers are dried over Na2SO4, filtered and concentrated in vacuo. The residue is dissolved in N,N-dimethylformamide (1.0 ml), treated with DBU (0.43 ml, 2.9 mmol, 10 equiv) and stirred under an atmosphere of argon for 5 minutes at 110° C. After cooling, the reaction mixture is diluted with water and extracted three times with EtOAc. The combined organic layers are washed with brine, dried over Na2SO4, filtered and concentrated in vacuo.

Aufarbeitung

  1. extractionAfter three extractions with EtOAc
  2. dry with materialthe combined organic layers are dried over Na2SO4
  3. filtrationfiltered
  4. concentrationconcentrated in vacuo
  5. dissolutionThe residue is dissolved in N,N-dimethylformamide (1.0 ml)
  6. stirringstirred under an atmosphere of argon for 5 minutes at 110° C
  7. temperatureAfter cooling
  8. extractionextracted three times with EtOAc
  9. washThe combined organic layers are washed with brine
  10. dry with materialdried over Na2SO4
  11. filtrationfiltered
  12. concentrationconcentrated in vacuo

Quellen und Nachweise

ORD-Eintrag
ord-dfa6120415144f6ea5d8e4e66450c801
Quelldatensatz
uspto-grants-2014_06
Patentnummer
US08742132B2

Verknüpfte Notizen

Wird geladen…